Professional Documents
Culture Documents
www.elsevier.com/locate/ejpb
Research paper
Abstract
We describe a drug delivery system based on a physically cross-linked poly(vinyl alcohol) (PVA) hydrogel for the release of Theoph-
ylline (TH). A composite was created by freezing an aqueous solution of PVA/NaOH onto a PVA/poly(acrylic acid) substrate. This
formed a strong interface and demonstrated greater physical strength than the hydrogel alone. Such systems have potential for a variety
of localised controlled drug delivery applications, for example, as coatings for implantable devices. Importantly, the results suggest that a
versatile synthetic platform is possible that may provide different functional materials or combination of such. The resultant samples
were characterised using optical microscopy, modulated differential scanning calorimetry (MDSC) and dissolution testing. The micro-
structure of the gels was examined using micro-thermal analysis (lTA) which is a combination of atomic force microscopy and thermal
analysis. TH was found to have an effect on the crystalline structure and dissolution showed a Fickian release, suggesting that swelling
and crystallinity were the controlling mechanisms.
2007 Elsevier B.V. All rights reserved.
0939-6411/$ - see front matter 2007 Elsevier B.V. All rights reserved.
doi:10.1016/j.ejpb.2007.02.014
378 M.J.D. Nugent, C.L. Higginbotham / European Journal of Pharmaceutics and Biopharmaceutics 67 (2007) 377–386
cross-linking, and the nature of the incorporated drug and Solutions were prepared by mixing polymer powder
typically follow first-order kinetics [16,17]. Shaheen et al. (1 g) with distilled water (40 ml) and 0.025 M NaOH and
discussed the use of PVA/NaCl/H2O systems for the deliv- 0.3 g of TH. Dissolution was achieved by heating the mix-
ery of TH [18,19]. The drug release behaviour showed an ture to 80 C for 90 min, while slowly stirring. When solids
irregular Fickian diffusion. Typically, the degree of PVA were no longer apparent and the mixture was clear, the
hydrogel cross-linking, which is intimately linked with the beaker containing the solution was placed in an ultra sonic
mechanical properties and water content, influences drug bath at 70 C for 5 min to remove all bubbles.
release properties [6].
The drug TH, used in the research, may be classified 2.1.2. Preparation of film component
according to the biopharmaceutics classification system as PAA with a weight average molecular weight of
a Class 1 compound which has a high solubility, high per- 3,000,000 was supplied by Aldrich. Solutions were pre-
meability and is very well absorbed [20]. Szepes et al. found pared by mixing 66% PVA and 34% PAA in 300 ml of dis-
that a freeze-casting technique was suitable for the formu- tilled water. Dissolution was achieved by heating to 80 C,
lation of porous dosage forms using TH as an active phar- while slowly stirring for about 90 min. When the polymers
maceutical ingredient (API) and potato starch as a filler. were no longer apparent the solution was placed in an ultra
The physical properties of TH, such as poor flowability sonic bath at 70 C for 5 min to remove all bubbles. The
and thermal stability under freeze process conditions, allow solution was then cast onto a Teflon coated glass basin
TH to be a good candidate for this technique [21]. and left in an oven at 80 C for 24 h.
The characterisation of drug systems may be performed
with a range of methods. Amongst the different techniques
2.1.3. Preparation of composite
is microthermal analysis (lTA). For lTA, the conventional
The dried PVA/PAA film was placed in a beaker and
atomic force microscopy (AFM) tip is replaced, with a
the aqueous solution containing PVA/NaOH/H2O was
miniature heater thermometer which enables a surface to
added. This beaker was placed in a trough and approx-
be visualised, according to its response to the input of heat
imately 500 ml of liquid nitrogen was added to the
[22]. On rastering over the sample surface, the topography
trough over a period of 10 min. The solidified solution
is obtained in an identical manner to that found for AFM
was allowed to thaw at room temperature for 24 h
(albeit at lower resolution due to the large size of the tip).
resulting in a composite of hydrogel and film. Fig. 1
The probe can be utilised as an ultra miniature differential
shows a picture of the film aspect of the composite,
thermal analyser, allowing a comparison of the electrical
while Fig. 2 shows a picture of the hydrogel aspect of
energy supplied to the probe and the surface [22].
the composite.
In previous work in our laboratory we have studied the
effect of the addition of sodium chloride, sodium hydroxide
and hydrochloric acid on the production of freeze-thawed
PVA gels and we found that gels with enhanced properties
were possible [23]. We presently report the development of
a composite (PVA–NaOH hydrogel/PVA PAA film) TH
drug delivery system, which exhibits Fickian diffusion. Bio-
medical applications of such systems are biomedical mem-
branes or coatings of in-dwelling medical devices.
Furthermore, a detailed characterisation of the thermal,
micro-structure properties of the composite, as well as a
drug release study were undertaken.
was produced. Fig. 3 shows a detailed photograph of the Upon drying of TH, Phadnis and Suryanarayanan postu-
interface of the film and gel. The hydrogel and the film lated that a transition in the region of 145 could be attrib-
have formed a cohesive structure. The PVA/PAA film uted to the solid to solid transition of a metastable
maintained its integrity, even though it has become anhydrous TH [29].
imbibed with water. The film gives the composite structural Fig. 4 shows the thermograms of the samples without
integrity while the hydrogel provides a reservoir for drugs. any TH present. The melting point of PVA is at 205 C.
To achieve sustained release, which is independent of the The addition of NaOH results in an increase in the melting
drug molecular weight, compounds may be entrapped in a point of PVA to 228 C and is consistent with previous
second phase, which is subsequently incorporated into the work [23]. The endotherm present in the region of 92 C
drug delivery system [25]. In the system described by the for the samples is due to the evaporation of residual water
authors, only the hydrogel acts as the drug reservoir, how- [27]. Upon cooling there is only one endotherm present for
ever it may be possible to incorporate an API into the PVA at 121 C, which may be due to the b relaxation [27].
PVA/PAA film. The principal challenge with a two-phase Fig. 5 shows the thermograms of PVA/NaOH/TH
system is in achieving high drug loading in the second and PVA/TH samples and TH on its own. The melting
phase. Two-phase systems have been investigated to con- point of TH is 274 C and it shows no other transitions,
trol API release profiles. These systems include the entrap- upon cooling there is a crystallisation endotherm at
ment of liposomes [26]. 255 C. For the PVA/NaOH/TH sample, as the temper-
ature is ramped up, a transition is shown at 152 C and
3.2. Modulated differential scanning calorimetry upon cooling another transition is present at 166 C.
These transitions may be due to the solid to solid tran-
PVA exhibits transitions at 85 C, 143 C and a large sition of a metastable anhydrous TH [29] or the crystal-
peak above 210 C. The peak at 85 C, known as the a line b relaxation of PVA [27]. It is interesting that this
relaxation, represents the glass transition temperature of transition is not present in the PVA/NaOH samples
PVA. The relaxation observed at 143 C, designated as devoid of TH and would indicate that TH is the primary
the b relaxation, is due to the relaxation in the PVA crys- cause. The addition of TH to PVA/NaOH results in a
talline domains. The third relaxation, which occurs at a reduced melting point of 203 C, suggesting that TH
temperature between 200 and 260 C, is caused by the melt- interferes with the crystalline structure. The melting point
ing of the crystalline domains of PVA [27]. As discussed of TH, in the PVA/NaOH/TH samples, is masked and is
previously by the authors, crystallinity increases with the not clearly visible. The melting point of the PVA/TH
addition of certain concentrations of NaOH for PVA samples is essentially the same at 210 C. A transition
hydrogels [23]. is present upon cooling at 127 C and is similar to the
The melting temperature of TH is 270 C [28]. When transition present in Fig. 4 and may be due to the crys-
placed in contact with water at ambient temperature, anhy- talline relaxation of PVA or the transition of a metasta-
drous TH is known to transform to TH monohydrate [29]. ble anhydrous [27,29].
Fig. 6. Dried sample of PVA/theophylline: topography pixel image and thermal conductivity image with corresponding intensity histograms.
Fig. 7. Dried sample of PVA: topography pixel image and thermal conductivity image with corresponding intensity histograms.
the surface and the temperature ramped linearly with time. of the cantilever is measured. When the probe is placed on
The power required to raise the temperature gives a calo- the surface, the cantilever is bent to a predetermined extent
rimetry signal [33]. In addition to calorimetry, the position ensuring a controlled force on the tip. As the temperature
M.J.D. Nugent, C.L. Higginbotham / European Journal of Pharmaceutics and Biopharmaceutics 67 (2007) 377–386 383
Fig. 8. Dried sample of PVA/NaOH: topography pixel image and thermal conductivity image with corresponding intensity histograms.
were calculated
p from Figs. 12 and 13. These were p 4.6 (%
release/ min) for PVA/NaOH and 5.6 (% release/ min)
for PVA on its own. The slower rate from PVA/NaOH is
probably due to the increased crystallinity of PVA/NaOH
sample, which retards the release of the drug. In crystalline
materials such as TH, hydrogen bonding is relatively weak,
though it has been reported that there was a decrease in
drug release from TH microcrystalline cellulose pellets pre-
pared by wet granulation due to the formation of addi-
tional binding of TH and the microcrystalline cellulose [32].
100
80
% release
60
40
20
0
0 5 10 15 20 25 30
1
t (min 2 )
Fig. 12. Drug release profiles from PVA/NaOH/H2O hydrogels in a Fig. 13. Drug release profiles from PVA/H2O hydrogels in a phosphate
phosphate buffer of pH 7.2 at 37 C. buffer of pH 7.2 at 37 C.
M.J.D. Nugent, C.L. Higginbotham / European Journal of Pharmaceutics and Biopharmaceutics 67 (2007) 377–386 385
TH forms a monohydrate in the presence of water and of the composite. Such composites with enhanced swelling
additional interactions may occur between TH and the and physical properties show promise for a variety of appli-
PVA. The relatively fast release may be attributed to the cations in the biomedical and pharmaceutical areas.
high water content of the hydrogel (>90%). To achieve sus-
tained release which is independent of the drug molecular
Acknowledgements
weight, compounds may be entrapped in a second phase
which is incorporated into the hydrogel [25].
This study was supported in parts by grants from both
Enterprise Ireland and the Athlone Institute of Technology
4. Conclusion
Research and Development Fund.
The results of this study permitted the conclusion that
this novel composite technique is suitable for the formula- References
tion of porous dosage forms containing TH as an API. The
[1] A.S. Hoffman, Hydrogels for biomedical applications, J. Adv. Drug
potential applications of PVA hydrogels are limited by
Deliv. Rev. 43 (2002) 3–12.
weak strength and previous studies, by the authors, showed [2] B. Jong, A. Gutowska, Lessons from nature: stimuli-responsive
that the physical stability of freeze thawed PVA hydrogels polymers and their biomedical applications, Trends Biotechnol. 20
was improved using NaOH. TH was incorporated into (2002) 305–311.
such a PVA hydrogel and its stability was further modified [3] A.B. Scranton, B. Rangarajan, J. Klier, Biomedical applications of
polyelectrolytes, J. Adv. Polym. Sci. 122 (1995) 1–44.
by the combination of the hydrogel and film into a novel
[4] C.L. Bell, N.A. Peppas, Biomedical membranes from hydrogels and
composite. interpolymer complexes, J. Adv. Polym. Sci. 122 (1995) 126–177.
The thermal properties of the various components were [5] S.R. Stauffer, N.A. Peppas, Polyvinyl alcohol hydrogels prepared by
examined, as variations in the degree of crystallinity in a freezing thawing cyclic processing, J. Polym. 33 (1992) 3932–3936.
pharmaceutical substance may exhibit physiochemical dif- [6] C.M. Hassan, N.A. Peppas, Structure and applications of
poly(vinyl alcohol) hydrogels produced by conventional crosslink-
ferences that impact at therapeutic, manufacturing, com-
ing or by freezing/thawing methods, J. Adv. Polym. Sci. 153
mercial and legal levels. (2000) 37–65.
This effect is further complicated when physically cross- [7] T. Shiga, H. Yoshiharu, A. Okada, K. Toshio, Bending of poly(vinyl
linked hydrogels are used to incorporate an API as these alcohol)-poly(sodium acrylate) composite hydrogel in electric fields, J.
hydrogels rely on hydrogen bonding and/or crystalline Appl. Polym. Sci. 44 (1992) 249–253.
[8] S.Y. Kim, S.S. Heung, M.L. Young, C.N. Jeong, Properties of
effects.
electroresponsive poly(vinyl alcohol)/poly(acrylic acid) IPN hydro-
The thermal analysis shows distinct endotherms relating gels under an electric stimulus, J. Appl. Polym. Sci. 73 (1999) 1656–
to the crystalline behaviour of PVA and the polymorphic 1683.
nature of TH. This was shown in the MDSC thermograms [9] A.S. Hickey, N.A. Peppas, Solute diffusion in poly(vinyl alcohol)/
where the melting of TH and PVA was examined. Other poly(acrylic acid) composite membranes prepared by freezing/thaw-
ing techniques, Polymer 38 (1997) 5931–5936.
effects that may be present are related to TH changing to
[10] S. Geresh, G.Y. Gdalevsky, I. Gilboa, J. Voorspoels, J.P. Remon, J.
a monohydrate and the relaxation of the crystalline regions Kost, Biodhesive grafted starch copolymers as platforms for peroral
of the PVA polymer. The lTA investigation of conductiv- drug delivery: a study of theophylline release, J. Control. Release 94
ity and topography suggested that TH was uniformly dis- (2004) 391–399.
tributed. The localised thermal analysis showed an [11] V.I. Lozinsky, A.L. Zubov, E.F. Titova, Poly(vinyl alcohol) cryogels
employed as matrices for cell immobilization. 2. Entrapped cells
endotherm similar to the recrystallisation of TH shown in
resemble porous fillers in their effects on the properties of PVA-
the MDSC results. This has implications for the analysis cryogel carrier, Enzyme Microb. Technol. 20 (1997) 182–190.
of hydrogels where thermal behaviour of drugs is masked [12] V.I. Lozinsky, F.M. Plieva, Poly(vinyl alcohol) cryogels employed as
by excipients. Micro-thermal analysis provides a greater matrices for cell immobilization. 3. Overview of recent research and
resolution and an increased confidence in analysis. developments, Enzyme Microb. Technol. 23 (1998) 227–242.
[13] A. Moretto, L. Tesolin, F. Marsilio, M. Schiavon, M. Berna, F.M.
The drug release behaviour of the PVA/H2O/NaOH and
Veronese, Slow release of two antibiotics of veterinary interest from
PVA/H2O hydrogels was Fickian and though not greatly PVA hydrogels, Il Farmaco 59 (2004) 1–5.
affected by the crystallinity, an effect is clearly present. A [14] K. Morimoto, S. Fukanoki, K. Morisaka, S.H. Hyon, Y. Ikada,
high release rate was also noted; however there may be Design of polyvinyl alcohol hydrogel as a controlled release vehicle
scope to modify the drug release behaviour, by the judi- for rectal administration of DL-propranolo-HCl and atenolol, Chem.
Pharm. Bull. 37 (1989) 2491–2495.
cious control of the film component of the composite
[15] N.A. Peppas, J.E. Scott, Controlled release from poly(vinyl alcohol)
substrate. gels prepared by freezing–thawing processes, J. Control. Release 18
Our work suggests that the creation of a composite is a (1992) 95–100.
useful technique for producing improved properties and [16] I. Galeska, T.K. Kim, S.D. Patil, U. Bhardwaj, D. Chatttopadhyay,
varying drug release behaviour. By varying such parame- F. Papadimitrakopoulos, D.J. Burgess, Controlled release of dexa-
methasone from PLGA microspheres embedded within polyacid-
ters as the initial aqueous concentration of PVA, molecular
containing PVA hydrogels, AAPS J. 7 (2005) 231–240.
weight of PVA, freezing and thawing conditions, the com- [17] A. Takamura, F. Ishii, H. Hidaka, Drug release from poly(vinyl
position of the substrate and by the use of different APIs, alcohol) gel prepared by freeze–thaw procedure, J. Control. Release
we can likely further modify and enhance the properties 20 (1992) 21–27.
386 M.J.D. Nugent, C.L. Higginbotham / European Journal of Pharmaceutics and Biopharmaceutics 67 (2007) 377–386
[18] S.M. Shaheen, K. Yamaura, Preparation of theophylline hydrogels of [32] C. Moji Adeyeye, J. Rowley, D. Madu, M. Javadi, S.S.
atactic poly(vinyl alcohol)/NaCl/H2O system for drug delivery, J. Sabnis, Evaluation of crystallinity and drug release stability of
Control. Release 81 (2002) 367–377. directly compressed theophylline hydrophilic matrix tablets
[19] S.M. Shaheen, K. Ukai, L. Dai, K. Yamaura, Properties of atactic stored under varied moisture conditions, Int. J. Pharm. 116
poly(vinyl alcohol)/NaCl/H2O system and their application for drug (1995) 65–75.
delivery, Polym. Int. 51 (2002) 1390–1397. [33] M. Reading, D.M. Price, D.B. Grandy, R.M. Smith, L. Bozec, M.
[20] G.L. Amidon, H. Lennernas, V.P. Shan, J.R. Crison, A theoretical Conroy, A. Hammiche, H.M. Pollock, Micro-thermal analysis of
basis for a biopharmaceutic drug classification: the correlation of polymers: current capabilities and future prospects, Macromol. Sym
in vitro drug product dissolution and in vivo bioavailability, Pharm. 167 (2001) 45–62.
Res. 12 (1995) 413–420. [34] W. Xie, J. Liu, C.W.M. Lee, W.P. Pan, The application of micro-
[21] A. Szepes, J. Ulrich, Z. Farkas, J. Kovács, P. Szabó-Révész, Freeze- thermal analysis technique in the characterization of polymer blend,
casting technique in the development of solid drug delivery systems, Thermochim. Acta 367-368 (2001) 135–142.
Chem. Eng. Process. 46 (2007) 230–238. [35] S.A. Edwards, M. Provatas, M. Ginic-Markovic, N. Roy Cho-
[22] D.M. Price, M. Reading, A. Hammiche, H.M. Pollock, Micro udhury, Probing the interface behaviour of injection molded
thermal analysis: scanning thermal microscopy and localised thermal thermoplastics by micro-thermal analysis and temperature-modu-
analysis, Int. J. Pharm. 192 (1999) 85–96. lated differential scanning calorimetry, Polymer 44 (2003) 3661–
[23] M.J.D. Nugent, A. Hanley, P.T. Tomkins, C.L. Higginbotham, 3670.
Investigation of a novel freeze–thaw process for the production of drug [36] G. Van Assche, A. Chanemn, O. Lhost, B. Van Mele, Through
delivery hydrogels, J. Mater. Sci.: Mater. Med. 16 (2005) 1149–1158. thickness analysis of the skin layer thickness of multi-layered
[24] N.A. Peppas, N.K. Mongia, Ultrapure poly(vinyl alcohol) hydrogels biaxially-oriented polypropylene films by micro-thermal analysis,
with mucoadhesive drug delivery characteristics, Eur. J. Pharm. Polymer 46 (2005) 7132–7139.
Biopharm. 43 (1997) 51–58. [37] P.G. Royall, D.Q.M. Craig, D.B. Grandy, The use of micro-
[25] A. Lalloo, P. Chao, P. Hu, S. Stein, P.J. Sinko, Pharmacokinetic and thermal analysis as a means of in situ characterisation of a
pharmacodynamic evaluation of a novel in situ forming poly(ethylene pharmaceutical tablet coat, Thermochim. Acta 380 (2001) 165–
glycol)-based hydrogel for the controlled delivery of camptothecins, J. 173.
Control. Release 112 (2006) 333–342. [38] M. Provatas, S.A. Edwards, N.R. Choudhury, analysis Surface finish
[26] E. Ruel-Gariepy, G. Leclair, P. Hildgen, A. Gupta, J.C. Leroux, of injection moulded materials by micro-thermal, Thermochim. Acta
Thermosensitive chitosan-based hydrogel containing liposomes for 392-393 (2002) 339–355.
the delivery of hydrophilic molecules, J. Control. Release 82 (2002) [39] N. Markovic, S. Agotonovic-Kustrin, B. Glass, C.A. Prestidge,
373–383. Physical and thermal characterisation of chiral omeprazole sodium
[27] C.M. Hassan, J.H. Ward, N.A. Peppas, Modeling of crystal disso- salts, J. Pharm. Biomed. Anal. 42 (2006) 25–31.
lution of poly(vinyl alcohol) gels produced by freezing/thawing [40] P.G. Royall, Q.M. Duncan, D.Q.M. Craig, D.M. Price, M. Reading,
processes, Polymer 41 (2000) 6729–6739. T.J. Lever, An investigation into the use of micro-thermal analysis for
[28] J.G. Fokkens, J.G.M. van Amelsfoort, C.J. de Blaey, C.G. de kruif, J. the solid state characterisation of an HPMC tablet formulation, Int.
Wilting, A thermodynamic study of the solubility of theophylline and J. Pharm. 192 (1999) 97–103.
its hydrate, Int. J. Pharm. 14 (1983) 79–93. [41] J.S. Park, J.W. Park, E. Ruckenstein, Thermal and dynamic
[29] N.V. Phadnis, R. Suryanarayanan, Polymorphism in anhydrous mechanical analysis of PVA/MC blend hydrogels, Polymer 42
theophylline implications on the dissolution rate of theophylline (2001) 4271–4280.
tablets, J. Pharm. Sci. 86 (1997) 1256–1263. [42] N.A. Peppas, Analysis of Fickian and non-Fickian drug release from
[30] M. Watase, K. Nishinar, Rheological and DSC changes in poly(vinyl polymers, Pharm. Acta Helv. 60 (1985) 110–111.
alcohol) gels induced by immersion in water, J. Polym. Sci. 23 (1985) [43] A.S. Hickey, N.A. Peppas, Mesh size and diffusion characteristics of
1803–1811. semicrystalline PVA membranes prepared by freezing thawing tech-
[31] R. Ricciardi, F. Auriemma, C. Gaillet, C. De Rosa, F. Laupretre, niques, J. Membr. Sci. 107 (1995) 229–237.
Investigation of the crystallinity of freeze/thaw poly(vinyl alcohol) [44] V.A. Trask, W.D.S. Motherwell, W. Jones, Physical stability
hydrogels by different techniques, Macromolecules 38 (2004) 9510– enhancement of theophylline via cocrystallization, Int. J. Pharm.
9516. 320 (2006) 114–123.